Fouad I. Ghaly MD FCCP
A graduate from the University
of Alexandria Medical School, Egypt then completing his residency at
Johns Hopkins Hospital in Baltimore, Maryland. His own heart attack
changed his expertise from cardiovascular anesthesiology to the practice
of longevity medicine.
Enhanced External Counterpulsation (EECP):
A Non-Invasive Out Patient Procedure to Revascularize the Heart Muscle without Open Heart Surgery.
The heart and cardiovascular system play such pivotal roles in maintaining our overall health and fitness that taking measures to insure heart health is vital to any anti-aging or longevity program. In a 2005 study published in Heart Failure Monitor, Gielen, et al noted the striking similarities between aging and chronic heart failure, including “exercise intolerance, reduced cardiac functional reserve during exercise, and loss of skeletal muscle mass as a result of inflammation and catabolism.” They also described vascular aging as a “progressive decrease in flow-mediated, endothelium-dependent vasodilation” and showed that aging of the cardiovascular system could begin in individuals as young as 25-35 years of age. In addition, Lakatta and Levy state in a 2003 paper published in Circulation, “There is a continuum of expression of cardiac structural and functional alterations that occurs with age in healthy humans, and these age-associated cardiac changes seem to have relevance to the steep increases in LVH, chronic heart failure, and AF seen with increasing age.” It is clear that taking steps to maintain cardiovascular health is an essential component of any Longevity or Rejuvenation Program.
No matter how much we may wish otherwise, the fact remains that we cannot stop Time. But is there anything that we can to stop or even reverse the harmful effects that aging and atherosclerosis have on the heart and cardiovascular system? Fortunately, there is. Enhanced External Counterpulsation (EECP) is a 50-year-old, non-invasive technology that has proven to be a safe and effective alternative or complement to invasive, high-risk procedures such as angioplasty and bypass surgery. Unlike these conventional treatments that target individual blockages, EECP treats heart disease as chronic system-wide illness. By recruiting and helping to develop new collateral blood vessels, EECP maximizes blood flow to the heart, as well as throughout the entire body.
View .pdf of Presentation here!